4//SEC Filing
Gold Lawrence Marshall 4
Accession 0001213900-22-028976
CIK 0001690080other
Filed
May 22, 8:00 PM ET
Accepted
May 23, 4:32 PM ET
Size
7.9 KB
Accession
0001213900-22-028976
Insider Transaction Report
Form 4
Gold Lawrence Marshall
Director
Transactions
- Award
Common Stock
2022-05-19$1.36/sh+10,570$14,375→ 22,028 total - Award
Non-Qualified Stock Option (right to buy)
2022-05-19+15,000→ 15,000 totalExercise: $1.36Exp: 2032-05-19→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]Issued in consideration for serving on the Board of Directors, as a Member of the Audit and Compensation Committee of the Board of Directors, and as Chairman of the Nominating and Corporate Governance Committee of the Board of Directors, for the quarter ended March 31, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
- [F2]Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
- [F3]The Options vest at the rate of 1/39th of such options ratably on a monthly basis over the following 39 months following the grant date, on the last day of each calendar month (beginning on May 31, 2022), subject to the holder's continued service to the Company.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001355868
Filing Metadata
- Form type
- 4
- Filed
- May 22, 8:00 PM ET
- Accepted
- May 23, 4:32 PM ET
- Size
- 7.9 KB